← back to search

Larissa Henze

Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DE
Area of research
Infectious Diseases · Immunology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immunotherapy and Immune Responses, and Advanced Breast Cancer Therapies.
h-index
12
citations
2,135
works
28
NIH funding
primary concept
Medicine
email

Recent publications

Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderly
Cell Reports 2025cited by 4position: middledoi
Aging and Viral Evolution Impair Immunity Against Dominant Pan‐Coronavirus‐Reactive T Cell Epitope
European Journal of Immunology 2025cited by 1position: middledoi
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation
Frontiers in Immunology 2023cited by 14position: middledoi
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Frontiers in Immunology 2023cited by 8position: firstdoi
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
Journal of Neurology Neurosurgery & Psychiatry 2022cited by 31position: middledoi
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly
The Journal of Immunology 2022cited by 23position: middledoi
Cross-reactive CD4 <sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Science 2021cited by 312position: middledoi
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Nature 2020cited by 1,395position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lucie Loyal · Siemens (Hungary)6 papers (2022–2025)Beate Kruse · Berlin Institute of Health at Charité - Universitätsmedizin Berlin5 papers (2022–2025)Andreas Thiel · Martin Luther University Halle-Wittenberg5 papers (2022–2025)Lil Meyer‐Arndt · Max Delbrück Center5 papers (2022–2025)Manuela Dingeldey · Berlin-Brandenburger Centrum für Regenerative Therapien5 papers (2022–2025)Julian Braun · Humboldt-Universität zu Berlin5 papers (2022–2025)Claudia Giesecke‐Thiel · Max Planck Institute for Molecular Genetics4 papers (2022–2025)Ulf Reimer · JPT Peptide Technologies (Germany)4 papers (2022–2025)Andreas Nitsche · Zuse Institute Berlin4 papers (2022–2025)Maike Mangold · Berlin Institute of Health at Charité - Universitätsmedizin Berlin4 papers (2022–2025)Janine Michel · European Molecular Biology Laboratory3 papers (2023–2025)Holger Wenschuh · JPT Peptide Technologies (Germany)3 papers (2023–2025)Florian Klein · Chirurgische Universitätsklinik Heidelberg3 papers (2022–2025) · 3 papers (2023–2025) · 3 papers (2023–2025)Leif Erik Sander · Charité - Universitätsmedizin Berlin3 papers (2022–2025)Karsten Jürchott · Charité - Universitätsmedizin Berlin3 papers (2022–2025)Bernd Timmermann · Max Planck Institute for the Study of Societies2 papers (2023–2025)Friedemann Paul · Max Delbrück Center2 papers (2022–2022)Norbert Mages · Max Planck Institute for Molecular Genetics2 papers (2023–2025)